European Court of Justice Rules Embryonic Stem Cell Research Not Patentable
October 19, 2011 9:47 AM
comment(s) - last by
European scientists worry that their research will instead flourish overseas
Embryonic stem cells have shown that they could eventually be
very useful in the treatment
of a range of currently incurable diseases such as diabetes, stroke and heart disease. But such research may be threatened, or even halted, in Europe due to a recent court decision.
Embryonic stem cells have the ability to transform into any human body tissue. For instance, earlier this year, the
first eye was grown
from embryonic stem cells in mice. But to grow these tissues, stem cells must be removed from a human embryo at the blastocyst stage, which destroys the embryo, and this has raised ethical questions regarding the process.
Greenpeace in Germany triggered a lawsuit saying that it is unethical to issue a patent based on stem cells from a human embryo that is destroyed afterward.
The Court of Justice, Europe's highest court, ruled in favor of the group. The ruling focused on a technique involving the conversion of human ambryonic stem cells into nerve cells.
"The use of human embryos for therapeutic or diagnostic purposes which are applied to the human embryo and are useful to it is patentable," said the European Court of Justice. "But their use for purposes of scientific research is not patentable. A process which involves removal of a stem cell from a human embryo at the blastocyst stage, entailing the destruction of that embryo, cannot be patented."
The decision has many European researchers outraged. This ruling could either halt
stem cell research
in Europe or send it overseas.
"This unfortunate decision by the court leaves scientists in a ridiculous position," said Professor Austin Smith of the Wellcome Trust Centre for Stem Cell Research at the University of Cambridge. "We are funded to do research for the public good, yet prevented from taking our discoveries to the marketplace where they could be developed into new medicines. One consequence is that the benefits of our research will be reaped in America and Asia."
This article is over a month old, voting and posting comments is disabled
10/19/2011 11:39:06 AM
I worked at Pfizer and they were the first patent trolls I thought of when seeing this. They wanted to patent the disease/cause so even if someone else finds a cure they reap some rewards. No love for humanity there you should all be on medication.
"We shipped it on Saturday. Then on Sunday, we rested." -- Steve Jobs on the iPad launch
Stem Cell Technique Produces Colonies of Blood Cells from Patient's Existing Cells
July 18, 2011, 10:15 AM
First Eye Grown from Embryonic Stem Cells in Mice
April 7, 2011, 9:22 AM
Researchers Announce First Clinical Trial for Stem Cell Therapy
October 12, 2010, 10:19 AM
Creationists are Mad About Google Doodle Depicting Evolution
November 24, 2015, 8:48 PM
DHS and TSA: Whoops, We Missed That 73 Airport Employees May be Terrorists
November 19, 2015, 2:16 PM
Star Wars Spinoff Film "Rogue One", Theme Park Attractions Announced
August 17, 2015, 12:20 PM
SpaceX Falcon 9's Seventh Supply Mission to ISS Ends w/ Fiery Stage 1 Explosion
June 28, 2015, 1:10 PM
Cool Science Video: Glowing Millipede Prowls the Nevada Desert
May 18, 2015, 12:00 PM
Newly Discovered Costa Rican Glass Frog is Kermit's Doppelgänger
April 22, 2015, 11:26 AM
Latest Blog Posts
Sceptre Airs 27", 120 Hz. 1080p Monitor/HDTV w/ 5 ms Response Time for $220
Dec 3, 2014, 10:32 PM
Costco Gives Employees Thanksgiving Off; Wal-Mart Leads "Black Thursday" Charge
Oct 29, 2014, 9:57 PM
"Bear Selfies" Fad Could Turn Deadly, Warn Nevada Wildlife Officials
Oct 28, 2014, 12:00 PM
The Surface Mini That Was Never Released Gets "Hands On" Treatment
Sep 26, 2014, 8:22 AM
ISIS Imposes Ban on Teaching Evolution in Iraq
Sep 17, 2014, 5:22 PM
More Blog Posts
Copyright 2016 DailyTech LLC. -
Terms, Conditions & Privacy Information